In a large study of 429,595 adults aged 65 years or older, adjuvanted and high-dose influenza vaccines showed no significant ...

Flu activity is rising sharply in the U.S. this season with at least 7.5 million estimated cases so far, largely due to a new variant of influenza type A called subclade K. Subclade K emerged after ...

Antiviral treatment for influenza is underutilized among children and adolescents, with a decline in use since the COVID-19 pandemic. During the 2023-2024 season, only 41%-48% of hospitalized and 31% ...

Roche has signed a voluntary license agreement providing its popular influenza antiviral drug Xofluza (baloxavir marboxil) ...

Influenza is an acute respiratory disease that causes epidemics and pandemics in the human population of temperate regions. Influenza epidemics occur every year during the winter months, affecting ...

May 18 (Reuters) - Roche and the Medicines Patent Pool have signed a licensing agreement to expand access to the Swiss ...

Avian influenza can jump species from birds to humans, a fact that arouses concern for serious illness and broader human ...

Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. A severe and early flu surge this winter, driven by a dangerous ...

Wastewater surveillance may be able to predict flu outbreaks and distinguish which strain is predominant roughly a week ...